Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor- associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia

Blood

Volumn 90, Issue 7, 1997, Pages 2535-2540

  Peeters, Pieter ^b   Raynaud, Sophie D ^b   Cools, Jan ^b   Wlodarska, Iwona ^b   Grosgeorge, Josiane ^b   Philip, Patrick ^b   Monpoux, Fabrice ^b   Van Rompaey, Luc ^b   Baens, Mathijs ^b   Van Den Berghe, Herman ^b   Marynen, Peter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 12P; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; PRIORITY JOURNAL;

EID: 0030852328     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.7.2535     Document Type: Article

References (39)

1. Kowalczyk J, Sandberg AA: A possible subgroup of ALL with 9p-. Cancer Genet Cytogenet 9:383, 1983
2. Chilcote RR, Brown E, Rowley JD: Lymphoblastic leukemia with features associated with abnormalities of the short arm of chromosome 9. N Engl J Med 313:286, 1985
3. Pollack C, Hagemeijer A: Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1:541, 1987
4. Groupe Français de Cytogénétique Hématologique (GFCH): Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 7:10, 1993
5. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237, 1993
6. Raimondi SC, Williams DL, Callihan T, Peiper S, Rivera GK, Murphy SB: Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 68:69, 1986
7. Mitelman F (ed): Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Liss, 1994
8. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
9. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, Grosveld G: Translocation t(12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511, 1995
10. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, Van den Berghe H: TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 85:2848, 1995
11. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
12. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA: The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood 85:3662, 1995
13. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Brayward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the tel gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917, 1995
14. Peeters P, Wlodarska I, Baens M, Criel A, Selleslag D, Hagemeijer A, Van Den Berghe H, Marynen P: Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Res 57:564, 1997
15. Suto Y, Sato Y, Smith SD, Rowley JD, Bohlander SK: A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B-cell ALL cell line. Genes Chrom Cancer 18:254, 1997
16. Romana S, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4623, 1995
17. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR: TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985, 1995
18. Cayuela JM, Bruchel A, Orange C, Madani A, Auclerc MF, Daniel MT, Schaison G, Sigaux F: TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 88:302, 1996
19. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B: The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in acute lymphoblastic leukemia. Blood 87:2891, 1996
20. Mitelman F (ed): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
21. Raynaud SD, Baens M, Grosgeorge J, Rodgers K, Reid CDL, Dainton M, Fuzibet JG, Gratecos N, Taillan B, Ayraud N, Marynen P: Fluorescence in situ hybridization analysis of t(3;12)(q26;p13): A recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood 88:682, 1996
22. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, Van Den Berghe H: Successful use of the same slide for consecutive fluorescence in situ hybridization experiments. Genes Chrom Cancer 16:261, 1996
23. Altschul SF, Miller WW, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 215:403, 1990
24. Baens M, Peeters P, Guo C, Aerssens J, Marynen P: Genomic organization of TEL: The human ETS-variant gene 6. Genome Res 6:404, 1996
25. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429, 1993
26. Pritchard MA, Baker E, Callen DF, Sutherland GR, Wilks AF: Two members of the JAK family of protein kinases map to chromosomes 1p31.3 and 9p24. Mamm Genome 3:36, 1992
27. Wilks AF, Oates AC: The JAK/STAT pathway. Cancer Surv 27:139, 1996
28. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
29. Schindler C, Darnell JE Jr: Transcriptional responses to polypeptide ligands: The JAK/STAT pathway. Annu Rev Biochem 64:621, 1995
30. Harrison AD, Binari R, Nahreini TS, Gilman M, Perrimon N: Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J 14:2857, 1995
31. Xu X, Kang SH, Heidenreich O, Okerholm M, O'Shea JJ, Nerenberg MI: Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J Clin Invest 96:1548, 1995
32. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM: Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 379:645, 1996
33. Sakai I, Nabell L, Kraft AS: Signal transduction by a CD16/CD7/Jak2 fusion protein. J Biol Chem 270:18420, 1995
34. Nakamura N, Chin H, Miyasaka N, Miura O: An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells. J Biol Chem 271:19483, 1996
35. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG: The TEL platelet-derived growth factor β receptor (PDGF/βR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc Natl Acad Sci USA 93:14845, 1996
36. Jousset C, Carron C, Boureux A, Quang CT, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J: A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. EMBO J 16:69, 1997
37. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
38. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H: Generation of the AML1-EVI1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504, 1994
39. ras-dependent manner. Proc Natl Acad Sci USA 93:11681, 1996